Millennium Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35,000
Closed -$1.05M 6432
2025
Q3
$1.05M Buy
+35,000
New +$1.17M ﹤0.01% 4598
2022
Q1
Sell
-5,000
Closed -$241K 7457
2021
Q4
$241K Buy
+5,000
New +$252K ﹤0.01% 5745
2018
Q1
Sell
-50,000
Closed -$1.4M 4051
2017
Q4
$1.4M Buy
50,000
+25,800
+107% +$788K ﹤0.01% 2497
2017
Q3
$750K Buy
+24,200
New +$658K ﹤0.01% 2659

Other funds holding SRDX

Millennium Management's SRDX Position: Q4 2025 in Review

Millennium Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 168,263 shares — an estimated $5.03M sold.

Millennium Management first reported a position in SRDX in Q2 2013 and held it in 47 quarters. The position peaked at $31.8M in Q2 2023. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Millennium Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Millennium Management sold 168,263 Surmodics shares in Q4 2025, an estimated $5.03M.
  • Millennium Management first reported a position in Surmodics in Q2 2013 and held it in 47 quarters.
  • Millennium Management's Surmodics position peaked at $31.8M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.